Reviva Pharmaceuticals Holdings Inc (RVPHW) — Financial Flexibility Index

Latest as of September 2025: -0.57x

Reviva Pharmaceuticals Holdings Inc (RVPHW) has a Financial Flexibility Index of -0.57x as of September 2025. Free cash flow of $-5.59 Million (operating CF $-5.59 Million minus capex $4.00) represents -1% of total liabilities ($9.78 Million). Also explore Reviva Pharmaceuticals Holdings Inc (RVPHW) net asset momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.57x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-5.59 Million
Operating CF − Capex

Total Liabilities

$9.78 Million
USD

Capital Expenditures

$4.00
USD

Reviva Pharmaceuticals Holdings Inc Financial Flexibility Index (2018–2024)

Historical Financial Flexibility Index trend for Reviva Pharmaceuticals Holdings Inc across 7 annual periods. Check financial resilience of Reviva Pharmaceuticals Holdings Inc to evaluate the company's liquid asset resilience ratio.

Annual Financial Flexibility Index for Reviva Pharmaceuticals Holdings Inc (2018–2024)

Year-by-year free cash flow to debt coverage for Reviva Pharmaceuticals Holdings Inc. For the full company profile including market capitalisation, see Reviva Pharmaceuticals Holdings Inc stock valuation.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -2.28x $-33.54 Million $-33.54 Million $14.69 Million ▼ -45.0%
2023 -1.58x $-28.32 Million $-28.32 Million $17.98 Million ▲ +12.5%
2022 -1.80x $-18.96 Million $-18.96 Million $10.53 Million ▲ +54.1%
2021 -3.93x $-10.67 Million $-10.67 Million $2.72 Million ▼ -218.2%
2020 -1.23x $-4.07 Million $-4.07 Million $3.30 Million ▼ -3748.1%
2019 -0.03x $-218.44K $-218.44K $6.81 Million ▲ +81.8%
2018 -0.18x $-1.07 Million $-1.07 Million $6.09 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities